TYGRIS: TYSABRI® Global Observational Program in Safety
The TYSABRI® Global Observational Program in Safety (TYGRIS) is a safety observational
cohort program designed to obtain long-term safety data in multiple sclerosis (MS) patients
treated with TYSABRI® in a clinical practice setting in the United States or Canada.
Observational Model: Cohort, Time Perspective: Prospective
To determine the incidence and pattern of serious infections, malignancies, and other serious adverse events (SAEs) in patients with Multiple Sclerosis (MS) treated with Tysabri.
United States: Food and Drug Administration
|There may be mulitple sites in this clinical trial. Contact United BioSource Corporation||Kansas City, Missouri 64111|